Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Journal of Rheumatic Diseases ; : 203-206, 2018.
Article in English | WPRIM | ID: wpr-715822

ABSTRACT

Raynaud syndrome is a medical condition that causes pain, numbness, and changes in skin color at the distal extremities. Raynaud syndrome can be subdivided into primary Raynaud's and secondary Raynaud's. The former is diagnosed when the cause is unknown and the latter is caused by an underlying condition, such as connective tissue diseases, injury, smoking, or certain medications. Both cancer chemotherapy and β-blockers are relatively common causes of Raynaud syndrome but there are no reports of its association with methimazole administration. The authors encountered a 43-year old woman with hyperthyroidism who developed digital ulcers associated with Raynaud syndrome after a methimazole treatment. Her digital ulcers and Raynaud syndrome were improved after methimazole was replaced with propylthiouracil and conventional therapy. This paper reports this case along with a review of the relevant literature.


Subject(s)
Female , Humans , Connective Tissue Diseases , Drug Therapy , Extremities , Hyperthyroidism , Hypesthesia , Methimazole , Propylthiouracil , Skin Pigmentation , Smoke , Smoking , Ulcer
SELECTION OF CITATIONS
SEARCH DETAIL